FDA 483 - NORTHEAST BIOLAB - December 05, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of NorthEast BioLab, a bioanalytical analytical facility in Hamden, CT, revealed a significant issue with method validation reporting. The firm failed to include all tested analytical batches in the run summary table of a method validation report, specifically omitting several batches related to standard stock comparison, precision & accuracy, and various stability tests. This indicates a concern with data integrity and complete documentation of analytical procedures.
- Person
ID · f549d6b8-52ef-4bd9-b587-11636694953a